STANDARD BIOTOOLS INC. (LAB)
Pharmaceutical Preparations
Latest Price
$0.69
TTM P/E
3.14
Normalized P/E
--
Div Yield
--
Book Value
1.39
P/B Ratio
0.50
Institutional Ownership
75.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Casdin Capital, LLC | 88.78M | $73.0M | 22.64% | -- | 2026-06-30 |
| VIKING GLOBAL INVESTORS LP | 58.65M | $48.0M | 14.96% | -- | 2026-06-30 |
| MAK CAPITAL ONE LLC | 28.81M | $23.0M | 7.35% | +2.64M | 2026-06-30 |
| Long Focus Capital Management, LLC | 23.50M | $19.0M | 5.99% | +7.48M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.25M | $10.0M | 3.12% | -563.1K | 2026-06-30 |
| BlackRock, Inc. | 8.25M | $6.0M | 2.11% | -16.50M | 2026-06-30 |
| Hollow Brook Wealth Management LLC | 5.50M | $4.0M | 1.40% | -150.0K | 2026-06-30 |
| NEUBERGER BERMAN GROUP LLC | 4.96M | $4.0M | 1.26% | +301.0K | 2026-06-30 |
| Qube Research & Technologies Ltd | 4.82M | $3.0M | 1.23% | +4.12M | 2026-06-30 |
| ROYCE & ASSOCIATES LP | 4.53M | $3.0M | 1.15% | +1.52M | 2026-06-30 |